Selected Case Studies

Winning with efficacy (Zocor®)
75% growth in 9 months (Prilosec®)
Re-igniting sales after a plateau (Vasotec®)
Defending market dominance (Timoptic®)
Market leader launching the second product into the same market (Prinivil®)

For full details on the above cases, please contact Larry Stoll for a presentation.

Prilosec, Prinivil, Timoptic, Vasotec, and Zocor are registered trademarks of Merck & Co., Inc.